LYTIR

Company · GTLB

GitLab Inc.

Name as listed on its exchange; filed with the SEC as Gitlab Inc.

Nasdaq's symbol directory lists GTLB on Nasdaq as “GitLab Inc. - Class A Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($248K); insiders sold on 7 occasions ($113.3M); 6 planned-sale notices; 1 filing by holders of 5% or more.

All insider filings at the SEC · Appeared in No. 31, No. 30, No. 29, No. 28, No. 6, No. 5, No. 4, No. 3

Insider purchases and sales, by month (last 12 months)Insider purchases: $248K in total; Insider sales: $113.3M in total.Jun: Insider purchases $123KJun: Insider sales $3.3MAug: Insider sales $332KSep: Insider purchases $125KSep: Insider sales $103.5MOct: Insider sales $6.2MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $248KInsider sales below: $113.3M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Sytse Sijbrandij sold on 5 days all under a 10b5-1 plan latest Oct 19, 2026 sold $110.6M
  2. Sivaprasad Padisetty, Chief Technology Officer sold on 1 day all under a 10b5-1 plan latest Sep 28, 2026 sold $2.4M
  3. Mundy Simon, Chief Accounting Officer sold on 1 day all under a 10b5-1 plan latest Aug 7, 2026 sold $332K
  4. William Staples, Chief Executive Officer bought on 2 days latest Sep 30, 2026 bought $248K
Every trade (9)
  1. SELLSytse Sijbrandij sold Oct 19, 2026 116,200 shares 2 legs combined 10b5-1 plan (scheduled) filing $6.2M
  2. BUYWilliam Staples, Chief Executive Officer bought Sep 30, 2026 2,677 shares 10b5-1 plan (scheduled) filing $125K
  3. SELLSytse Sijbrandij sold Sep 28, 2026 430,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $19.7M
  4. SELLSivaprasad Padisetty, Chief Technology Officer sold Sep 28, 2026 51,915 shares 3 legs combined 10b5-1 plan (scheduled) filing $2.4M
  5. SELLSytse Sijbrandij sold Sep 25, 2026 705,490 shares 2 legs combined 10b5-1 plan (scheduled) filing $33.7M
  6. SELLSytse Sijbrandij sold Sep 24, 2026 980,710 shares 2 legs combined 10b5-1 plan (scheduled) filing $47.7M
  7. SELLMundy Simon, Chief Accounting Officer sold Aug 7, 2026 8,725 shares 10b5-1 plan (scheduled) filing $332K
  8. BUYWilliam Staples, Chief Executive Officer bought Jun 30, 2026 4,188 shares 10b5-1 plan (scheduled) filing $123K
  9. SELLSytse Sijbrandij sold Jun 15, 2026 116,200 shares 2 legs combined 10b5-1 plan (scheduled) filing $3.3M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Sytse Sijbrandij Revocable Trust filed Oct 19, 2026 Director 348,600 shares planned sale date 10/19/2026 filing $18.4M
  2. ROBIN SCHULMAN filed Oct 9, 2026 Officer 49,936 shares planned sale date 10/09/2026 filing $2.7M
  3. SIMON MUNDY filed Oct 1, 2026 Officer 9,132 shares planned sale date 10/01/2026 filing $431K
  4. SIVAPRASAD PADISETTY filed Sep 28, 2026 Officer 51,915 shares planned sale date 09/28/2026 filing $2.4M
  5. SYTSE SIJBRANDIJ REVOCABLE TRUST filed Sep 24, 2026 Director 2,116,200 shares planned sale date 09/24/2026 filing $103.7M
  6. SIMON MUNDY filed Sep 18, 2026 Officer 2,934 shares planned sale date 09/18/2026 filing $147K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Sytse Sijbrandij filed Oct 30, 2026 Schedule 13G/A passive filing 8.5%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.